Molecule capable of halting and reverting neurodegeneration caused by Parkinson's disease identified | Salvador Ventura

Created by : Francis Goodwin View profile

Image credit: topag.mpg.deImage credit: topag.mpg.deSept. 25, 2018 (MedicalXpress) -- The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibers responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease, researchers have found.

The study, headed by Universitat Autònoma de Barcelona researchers, was published in PNAS.

Parkinson's disease is the second most common incurable neurodegenerative disorder after Alzheimer's disease. It is characterized by the accumulation of protein deposits in dopaminergic neurons in the form of amyloid fibers.

(more)

READ MORE: MedicalXpress

  • Categories
    Edited | Front Page Stories | All Content | Business | Health | Science | Europe | News | News -- WNT Selected | Slider
  • Date range
    Tuesday, September 25, 2018
  • Last modified
    Tuesday, September 25, 2018